Panther Fusion® Bordetella Assay
A fully-automated approach to testing Bordetella pertussis and Bordetella parapertussis in one single assay.1
Extending Performance & Automation
The Panther Fusion Bordetella assay is a multiplex, real-time PCR (RT-PCR) in-vitro diagnostic test for the rapid and qualitative detection and differentiation of Bordetella pertussis (Bp) and Bordetella parapertussis (Bpp) from nasopharyngeal swab specimens.1
Increase Efficiency & Reduce Costs
Personalise your patient testing by running the Panther Fusion Bordetella assay alone or in conjunction with other Panther Fusion respiratory assays.1
Protecting Children
Infants and young children are more likely to be diagnosed in the early phases of pertussis, where PCR and culture are the methods of choice. Young children are likely to have been recently vaccinated against pertussis and have elevated levels of antibodies, as a consequence serology results may be confounded.2
A High Prevalence Pathogen
The prevalence of B. pertussis and B. parapertussis combined is less than 2% and widely depends on the age of the patient. An estimated 16 million cases of pertussis and 195,000 associated deaths occur globally each year. In the European countries, approximately 40,000 cases are reported each year.1
Testing Variety
The assay can be run alongside current infectious disease, women’s health and virology assays, enabling laboratories to unlock the free capacity on their existing Panther Systems.
Simplify & Scale the Future of Diagnostics
The Panther Fusion Bordetella Assay is part of the Hologic Molecular Scalable Solution, a portfolio combining a broad, high-performing assay menu with high-throughput automation. Designed to flexibly scale to meet your needs, from a single patient result to population-level screening.
Be Prepared for the Winter Respiratory Season
The Panther Fusion assay shows excellent clinical performance.1
100%
sensitivity
Bordetella pertussis
96.8%
specificity
Bordetella pertussis
100%
sensitivity
Bordetella parapertussis
99.6%
specificity
Bordetella parapertussis
Right Patient. Right Test. Right Time.3
- From true on-demand testing to high-throughput
- No sample batch constraints, prioritise urgent samples
- First results in 2.4 hours
- Run multiple assays from a single specimen tube at the same time
- Single dose, ready-to-use-assay reagent cartridge
- Long onboard stability of fluids and reagents
Verified Sample Collection
The Panther Fusion Bordetella assay is validated for nasopharyngeal swabs in viral transport medium and universal transport medium.1
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
Insights
- Panther Fusion Bordetella assay [package insert]. AW-18637-001 Rev. 001 San Diego, CA: Hologic, Inc.; 2018
- European Centre for Disease Prevention and Control. Laboratory diagnosis and molecular surveillance of Bordetella pertussis - Stockholm: ECDC; 2022.
- Panther/Panther Fusion System Operator´s Manual. AW-26055-001 Rev 001, San Diego, CA: Hologic Inc.; 2022.
Safety Data Sheets
Package Inserts
2797
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
EC Representative Information wherever applicable
Notified Body number wherever applicable